Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases. Issue 3 (18th December 2019)
- Record Type:
- Journal Article
- Title:
- Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases. Issue 3 (18th December 2019)
- Main Title:
- Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases
- Authors:
- Martinelli, Chiara
Pucci, Carlotta
Battaglini, Matteo
Marino, Attilio
Ciofani, Gianni - Abstract:
- Abstract: Many central nervous system (CNS) diseases are still incurable and only symptomatic treatments are available. Oxidative stress is suggested to be a common hallmark, being able to cause and exacerbate the neuronal cell dysfunctions at the basis of these pathologies, such as mitochondrial impairments, accumulation of misfolded proteins, cell membrane damages, and apoptosis induction. Several antioxidant compounds are tested as potential countermeasures for CNS disorders, but their efficacy is often hindered by the loss of antioxidant properties due to enzymatic degradation, low bioavailability, poor water solubility, and insufficient blood–brain barrier crossing efficiency. To overcome the limitations of antioxidant molecules, exploitation of nanostructures, either for their delivery or with inherent antioxidant properties, is proposed. In this review, after a brief discussion concerning the role of the blood–brain barrier in the CNS and the involvement of oxidative stress in some neurodegenerative diseases, the most interesting research concerning the use of nano‐antioxidants is introduced and discussed, focusing on the synthesis procedures, functionalization strategies, in vitro and in vivo tests, and on recent clinical trials. Abstract : Nanotechnological approaches for antioxidant therapy of central nervous system diseases improve the bioavailability and the delivery of antioxidant molecules, prevent their degradation, and facilitate blood–brain barrier crossingAbstract: Many central nervous system (CNS) diseases are still incurable and only symptomatic treatments are available. Oxidative stress is suggested to be a common hallmark, being able to cause and exacerbate the neuronal cell dysfunctions at the basis of these pathologies, such as mitochondrial impairments, accumulation of misfolded proteins, cell membrane damages, and apoptosis induction. Several antioxidant compounds are tested as potential countermeasures for CNS disorders, but their efficacy is often hindered by the loss of antioxidant properties due to enzymatic degradation, low bioavailability, poor water solubility, and insufficient blood–brain barrier crossing efficiency. To overcome the limitations of antioxidant molecules, exploitation of nanostructures, either for their delivery or with inherent antioxidant properties, is proposed. In this review, after a brief discussion concerning the role of the blood–brain barrier in the CNS and the involvement of oxidative stress in some neurodegenerative diseases, the most interesting research concerning the use of nano‐antioxidants is introduced and discussed, focusing on the synthesis procedures, functionalization strategies, in vitro and in vivo tests, and on recent clinical trials. Abstract : Nanotechnological approaches for antioxidant therapy of central nervous system diseases improve the bioavailability and the delivery of antioxidant molecules, prevent their degradation, and facilitate blood–brain barrier crossing and targeting to the desired sites within the brain. … (more)
- Is Part Of:
- Advanced healthcare materials. Volume 9:Issue 3(2020)
- Journal:
- Advanced healthcare materials
- Issue:
- Volume 9:Issue 3(2020)
- Issue Display:
- Volume 9, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 9
- Issue:
- 3
- Issue Sort Value:
- 2020-0009-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2019-12-18
- Subjects:
- antioxidants -- central nervous system disorders -- drug delivery -- nanomaterials
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2192-2659 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/adhm.201901589 ↗
- Languages:
- English
- ISSNs:
- 2192-2640
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0696.854650
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12798.xml